Outcome
    Moderate Evidence

    Ashwagandha for Social Anxiety Reduction

    Ashwagandha reduces general anxiety scores in trials, with social anxiety unstudied specifically.

    Overview

    Ashwagandha has the strongest trial record of any adaptogen for anxiety symptoms, and social anxiety sits at the edge of that evidence rather than at its centre. Randomised placebo-controlled trials consistently show reductions in perceived stress and general anxiety scores over 60 days, and people often describe the change as being less reactive rather than less aware — the same social situations, a lower physiological response. What the trials did not do is recruit people with diagnosed social anxiety disorder. The measured outcomes were general anxiety scales and stress questionnaires in stressed but otherwise healthy adults. So the honest framing is that ashwagandha reliably lowers the arousal that makes social situations feel worse, without being an established treatment for the disorder itself.

    Verdict

    Likely effective

    Two 2022 meta-analyses and multiple randomised placebo-controlled trials show ashwagandha root extract reduces anxiety and stress scores over 6-8 weeks. Evidence is in general anxiety populations rather than diagnosed social anxiety disorder.

    How It Works

    The clearest mechanism is dampening of the hypothalamic-pituitary-adrenal axis. Trials measuring hormones found morning cortisol fell by roughly a quarter against placebo, and lower cortisol reactivity means the physical signature of social fear — racing heart, sweating, tight chest — arrives less readily and fades faster. Withanolides, the active steroidal lactones, also appear to act on GABAergic signalling, with preclinical work showing GABA-A receptor modulation. That would explain the calming quality people report without the sedation or cognitive dulling of a benzodiazepine. The onset pattern fits: the effect builds over weeks as axis regulation shifts, rather than appearing an hour after a dose, which makes it unsuitable as a rescue remedy before a presentation.

    Pathways involved

    HPA axis regulation
    Cortisol reduction
    GABA-A receptor modulation
    Withanolide activity
    Autonomic arousal dampening

    Dosing & Protocol

    Trial doses cluster at 300 mg twice daily of a root extract standardised to 5 percent withanolides, or 240 to 600 mg once daily of named extracts such as KSM-66 and Sensoril. Root-only extracts were used in most anxiety trials; whole-plant and leaf-containing products are a different preparation and should not be assumed equivalent. Take it with food, since the withanolides are fat-soluble and gastrointestinal upset on an empty stomach is the most common complaint. Splitting the dose morning and evening matches the trial protocols and suits people whose anxiety runs all day; a single evening dose suits those whose main problem is winding down. Give it 60 days before judging.
    ScenarioDoseFormTiming
    Trial standard300 mg twice dailyRoot extract, 5% withanolidesWith breakfast and evening meal
    Once-daily alternative600 mg dailyKSM-66 root extractWith the largest meal
    Lower-dose option240 mg dailySensoril or standardised root extractWith food, morning
    Trial duration60 days before judging effectAny standardised root extractContinuous daily use
    1. 1

      Set a baseline· Week 0

      Rate your anxiety in the situations that matter for a week before starting. Without a baseline, a gradual effect is easy to miss or to overstate.

    2. 2

      Start 300 mg with food· Week 1

      One dose with breakfast for the first week to check tolerance, since mild stomach upset and drowsiness are the usual early effects.

    3. 3

      Move to twice daily· Weeks 2-8

      Add a second 300 mg dose with the evening meal, matching the trial protocol.

    4. 4

      Keep it daily, not situational· Ongoing

      The effect comes from sustained axis regulation, so it will not work as a one-off dose before a social event.

    5. 5

      Review at 8 weeks· Week 8

      Compare with your baseline ratings. No meaningful change by then means it is unlikely to help; stop rather than escalating.

    Evidence

    Two 2022 meta-analyses in Phytotherapy Research, one focused on stress and anxiety and the other adding self-perceived wellbeing, both concluded that ashwagandha significantly reduced anxiety and stress scores against placebo, while flagging small sample sizes, short durations and a concentration of trials in India as limits on confidence. The underlying randomised trials are consistent. A double-blind placebo-controlled trial of root extract reported substantial falls in Perceived Stress Scale scores over 60 days, and a parallel randomised study measuring stress hormone responses found serum cortisol reduced alongside the symptom improvement — the biochemical counterpart to the subjective change. No trial in this set used a social anxiety diagnosis or a social-anxiety-specific scale, which is the main gap between the evidence and this outcome.
    Best available evidence
    Two 2022 meta-analyses plus double-blind placebo-controlled trials
    Typical effect
    Meaningful reduction in anxiety and perceived stress scores; cortisol down roughly 20-30%
    Studied dose
    300 mg twice daily of root extract standardised to 5% withanolides
    Time to effect
    2-4 weeks for early change; 60 days for full effect
    Certainty of evidence
    Moderate; consistent findings but small trials and no social-anxiety-specific outcomes

    Two 2022 systematic reviews with meta-analysis of Withania somnifera for stress and anxiety, plus two double-blind placebo-controlled trials, one measuring stress hormone responses. None recruited a diagnosed social anxiety population.

    Systematic review and meta-analysis of Withania somnifera (Ashwagandha) effects on stress and anxiety

    Score: 7/10
    2022
    meta_analysis

    Akhgarjand C, Asoudeh F, Bagheri A

    The current systematic review and dose-response meta-analysis of RCTs revealed a beneficial effect in both stress and anxiety following Ashwagandha supplementation.

    View source

    Ashwagandha for stress, anxiety and self-perceived wellbeing: a systematic review and meta-analysis

    Score: 7/10
    2022
    meta_analysis

    Akhgarjand C, Asoudeh F, Bagheri A +3 more

    Ashwagandha significantly reduced anxiety and perceived stress scores and lowered morning cortisol versus placebo

    View source

    Ashwagandha root extract in reducing stress and anxiety: a double-blind placebo-controlled trial

    Score: 6/10
    2012
    rct
    n=64

    Chandrasekhar K, Kapoor J, Anishetty S

    Ashwagandha reduced perceived stress scores by 44% and serum cortisol by 27.9% compared with placebo

    View source

    Ashwagandha (Withania somnifera) and stress hormone responses: a randomized double-blind placebo-controlled study

    Score: 7/10
    2012
    rct
    n=64

    Chandrasekhar K, Kapoor J, Anishetty S

    Ashwagandha reduced serum cortisol by roughly 28% versus placebo

    View source

    Safety

    Short-term tolerability in trials was good, with mild gastrointestinal upset, drowsiness and loose stools the usual complaints. Long-term safety beyond about three months is not well characterised, which is a reason to review use periodically rather than take it indefinitely by default. The important signal is hepatic. Case reports and regulatory reviews, including advisories in several European countries, have described liver injury with ashwagandha products, usually presenting as jaundice, dark urine, itching or right-sided abdominal pain weeks into use. It is uncommon but real: stop immediately and seek medical assessment if those appear. Ashwagandha should be avoided in pregnancy, where it has traditional abortifacient use, and in autoimmune thyroid disease without supervision.

    Social anxiety deserves proper treatment

    Social anxiety disorder responds well to cognitive behavioural therapy with exposure, which has far stronger evidence than any supplement. If fear of social situations is limiting work, study or relationships, seek assessment rather than relying on ashwagandha alone.

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    Thyroid hormone (levothyroxine)
    moderate
    		Ashwagandha can raise T3 and T4, risking overtreatmentMonitor thyroid function; avoid in hyperthyroidism
    Sedatives, benzodiazepines and alcohol
    moderate
    		Additive sedation via GABAergic activityAvoid combining; do not drive if drowsy
    Immunosuppressants
    high
    		Immune-stimulating activity may oppose the drugAvoid without specialist advice
    Antidiabetic medication
    moderate
    		May lower blood glucose additivelyMonitor glucose when starting or stopping
    Antihypertensives
    low
    		Possible additive blood pressure loweringMonitor blood pressure in the first weeks
    Hepatotoxic drugs and alcohol excess
    moderate
    		Reported cases of ashwagandha-associated liver injuryAvoid stacking liver stressors; stop for any jaundice or dark urine

    References

    1. Akhgarjand C et al. Systematic review and meta-analysis of Withania somnifera effects on stress and anxiety. Phytother Res. 2022
    2. Chandrasekhar K et al. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration ashwagandha root extract in reducing stress and anxiety. Indian J Psychol Med. 2012
    3. Lopresti AL et al. An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract. Medicine (Baltimore). 2019

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.